Partnering_Information.pdf - 37 K

Presenting Companies at Charité Partnering

• Amedrix GmbH, Esslingen: Based on a matrix consisting of type I collagen the company Amedrix GmbH develops and produces acellular implants (classified as medical device) for various applications in the human and veterinary sector.
• AmyloCure, Berlin: Small molecule therapeutics/diagnostics for Alzheimer and Huntington.
• Caprotec Bioanalytics GmbH, Berlin: We provide access to a superior technology for analyzing small molecule protein interactions e.g. to reduce adverse drug side effects.
• Cell Medica Limited, London/UK: Pathogenspecific Immunreconstitution in immunocompromised patients.
• CRP GmbH i.P., Berlin: CRP adsorber for myocardial infarction and stroke therapy.
• GHC Global Health Care GmbH, Berlin: Technology and service for a telemedical emergency service for airplanes.
• Humedics GmbH, Grossbeeren: We produce the LiMAxTM / FLIP TM system which is the first device exclusively designed for the real-time assessment of liver function in the exhaled gas flow.
• ILIAS-medical GmbH, Bochum: Mobile, artificial lung, ECMO System
• KINAXO Biotechnologies GmbH, Martinsried: Quantitative analysis of the cellular phosphoproteome to support the development of targeted cancer drugs and companion diagnostics.
• Kirsen Medical Technologies (KMT), Berkeley/ USA: KMT is the leader in Non-Contact Vital Signs Monitoring targeting the .4B market with Sleep Diagnostics as initial focus application.
• Medicyte GmbH, Heidelberg: Medicyte is a life science company, seeking further financing in order to leverage the full therapeutic and non-therapeutic potential of its novel high end primary cell products.
• Microstim, Luebeck: Development of a tissue and function preserving myostimulator for muscle powered cardiac assistance.
• Natural Dental Implants AG, Berlin, Early-stage dental technology and services company, making a 100% customized all-ceramic tooth replica, including an anatomically shaped root portion to osseointegrate or to regenerate the periodontal membrane.
• NeMoDevices AG, Kilchberg/Switzerland: NeMoDevices develops new neuromonitoring systems to optimize diagnosis and treatment of patients with stroke and brain injuries.
• NonWoTecc Medical GmbH, Köln: Novel biomimetic vascular prostheses.
• OrganOx Limited, Oxford/UK: A novel medical device for improving the quality and increasing the quantity of organs for transplantation.
• Particular GmbH, Hannover: Particular produces and employs nanoparticles for biomedicine (implant coatings, nanomarkers)
  using a new, non-chemical process that stands for large material variety and high purity.
• PluriSelelect GmbH, Leipzig: The pluriSelect develops, produces and sales cell separation technology.
• Parelectrics, Berlin: Device for noninvasive skin-cancer diagnostics with the ability to.
• Provecs Medical GmbH, Hamburg: We provide a unique validated platform of combinatorial immunotherapeutics that targets cellular networks in the immune system and delivers products for oncology, vaccines and anti-inflammatories.
• Scaffion, Berlin: Development of protein-interactions for the treatment of chronic heart failure.
• Scopis, Berlin: Scopis and markets measuring for different applications of minimal invasive surgery. The systems are based on specially development measuring sheaths, which upgrade conventional endoscopes toprecise laser measurement.
• SP Solution Pool GmbH, Berlin: Clinical Navigation Systems.
• Zedira GmbH, Darmstadt: Development of a celiac diesease drug until Phase IIa (PoC).

Members of the Jury

Michael Brandkamp

Stephan Gutzeit

Uwe Maschek

Joachim Rautter

Jens Schneider-Mergener

Klaus Stöckemann

Among the investors and institutions supporting entrepreneurs in the Summit were:

Investors attending the Summit

• Aescap Venture Management B.V., Amsterdam
• ARCH Venture Partners, San Francisco
• BayTech Venture Capital Beratungs GmbH
• B. Braun Melsungen AG, Melsungen
• Berlin Partner GmbH, Berlin
• Business Angels Network Deutschland, BAND, Essen
• Charité Beteiligungsfonds, Berlin
• Dr. Walter Rust, Business Angel, Berlin
• Dr. Bernd Wegener, Business Angel, Hennigsdorf
• Earlybird, Hamburg
• EXTOREL Private Equity Advisers, Munich
• Filarete Investimenti Spa (Seed Capital), Milan
• Freie Universitaet Berlin, profund, Berlin
• Gazelle Growth Fund, Copenhagen
• GB Unternehmensentwicklung, Charité - Universitaetsmedizin, Berlin
• GO:Incubator, Potsdam
• HealthCap, Stockholm
• High-Tech Gruenderfonds, Bonn
• HUMBOLDT-INNOVATION GmbH, Berlin
• IBB Beteiligungsgesellschaft mbH, Berlin
• Investitionsbank Berlin
• InVivo Biotech Services GmbH, Hennigsdorf
• JStone Innovation Management srl, Torino
• Lodestone IP, London
• Max-Planck-Innovation GmbH, Munich
• Medical Research Council Technology Fund, London
• Novartis Pharma Deutschland, Berlin
• PEPPERMINT. Financial Partners, Berlin
• Pfizer Europe, Berlin
• Pfizer Oncologie Europe
• Philips Healthcare Incubator, Eindhoven
• Projekttraeger Juelich, Berlin
• Proteus Venture Partners, Palo Alto
• Royal Society Enterprise Development Fund, London
• Seventure Partners, Paris
• Sofinnova, Paris
• Sopep, Koeln
• Technische Universitaet Berlin Gruendungsservice, Berlin
• Technologie Transfer, Charité - Universitaetsmedizin, Berlin
• TVM Capital GmbH, Munich
• Ventech, Paris
• VESALIUS BIOCAPITAL, Luxemburg
• Wellcome Trust, London
• Wellington Partners, Munich